lipid X; 86559-73-1; [(2R,3S,4R,5R,6R)-3-hydroxy-2-(hydroxymethyl)-5-[[(3R)-3-hydroxytetradecanoyl]amino]-6-phosphonooxyoxan-4-yl] (3R)-3-hydroxytetradecanoate; [(2R,3S,4R,5R,6R)-3-Hydroxy-2-(hydroxymethyl)-5-(3-hydroxytetradecanoylamino)-6-phosphonooxyoxan-4-yl] 3-hydroxytetradecanoate; 2,3-bis(3-hydroxytetradecanoyl)-alpha-D-glucosaminyl 1-phosphate; 2,3-bis[(3R)-3-hydroxymyristoyl]-alpha-D-glucosaminyl 1-phosphate; (R)-((2r,3s,4r,5r,6r)-3-Hydroxy-2-(Hydroxymethyl)-5-((R)-3-Hydroxytetradecanamido)-6-(Phosphonooxy)tetrahydro-2h-Pyran-4-Yl) 3-Hydroxytetradecanoate; Monosaccharide precursor, E coli lipid A; LP5; SCHEMBL10352307; CHEBI:16942; DTXSID901006919; 2,3-Diacylglucosamine 1-phosphate; HY-130581; CS-0109243; C04824; Q27102143; {[(2R,3R,4R,5S,6R)-5-Hydroxy-6-(hydroxymethyl)-3- [(3R)-3-hydroxytetradecanamido]-4-{[(3R)-3- hydroxytetradecanoyl]oxy}oxan-2-yl]oxy}phosphonic acid; 2-deoxy-3-O-[(3R)-3-hydroxytetradecanoyl]-2-{[(3R)-3-hydroxytetradecanoyl]amino}-1-O-phosphono-alpha-D-glucopyranose; alpha-D-Glucopyranose, 2-deoxy-2-((3-hydroxy-1-oxotetradecyl)amino)-, 1-(dihydrogen phosphate) 3-(3-hydroxytetradecanoate), (2(R),3(R))-; VJ1; WURCS=2.0/1,1,0/[a2122h-1a_1-5_1*OPO/3O/3=O_2*NCCC^RCCCCCCCCCCC/5O/3=O_3*OCCC^RCCCCCCCCCCC/5O/3=O]/1/